Literature DB >> 2571148

Expression of major histocompatibility complex class I antigens in rat muscle cultures: the possible developmental role in myogenesis.

H Honda1, A Rostami.   

Abstract

The expression of major histocompatibility complex class I antigens was demonstrated on aneurally cultured rat muscle cells. Myoblasts showed constitutive expression of class I antigens on their cell surfaces. The presence of the antigens was transitory, disappearing as myoblasts fused and differentiated into multinucleate myotubes. Furthermore, antibody against rat class I antigens showed an inhibitory effect on the generation of myotubes during muscle development. Although mature myotubes did not show any detectable levels of class I antigens on their cell surface, soluble factors from concanavalin A-activated spleen cells or interferon gamma could induce the expression of class I antigens on muscle fibers. These results suggest that the expression of class I antigens on muscle cells is not only immunologically modulated but also developmentally regulated and that the antigens may play a role in cell recognition and interactions during the fusion process of myogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571148      PMCID: PMC297981          DOI: 10.1073/pnas.86.18.7007

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

2.  Cell-cell adhesion mediated by CD8 and MHC class I molecules.

Authors:  A M Norment; R D Salter; P Parham; V H Engelhard; D R Littman
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

3.  The detailed distribution of HLA-A, B, C antigens in normal human organs.

Authors:  A S Daar; S V Fuggle; J W Fabre; A Ting; P J Morris
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

4.  Cell aggregation: its enhancement by a supernatant from cultures of homologous cells.

Authors:  J E Lilien; A A Moscona
Journal:  Science       Date:  1967-07-07       Impact factor: 47.728

5.  Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras.

Authors:  Y Matsumoto; M Fujiwara
Journal:  J Neuroimmunol       Date:  1987-12       Impact factor: 3.478

6.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

7.  Expression of immunoreactive major histocompatibility complex products in human skeletal muscles.

Authors:  G Karpati; Y Pouliot; S Carpenter
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

8.  Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.

Authors:  S T Appleyard; M J Dunn; V Dubowitz; M L Rose
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

9.  Effects of phorbol 12-myristate 13-acetate on the differentiation program of embryonic chick skeletal myoblasts.

Authors:  A A Dlugosz; S J Tapscott; H Holtzer
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

10.  Characterization of T-cell-soluble factors modulating the expression of Ia and H-2 antigens on BALB/c B lymphoma cell lines.

Authors:  K J Kim; G Chaouat; W M Leiserson; J King; E De Maeyer
Journal:  Cell Immunol       Date:  1983-03       Impact factor: 4.868

View more
  9 in total

1.  Comparative study of experimental autoimmune neuritis in SJL mice and Lewis rats.

Authors:  A Rostami
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.

Authors:  Shih-Wen Lin; Scott E Hensley; Nia Tatsis; Marcio O Lasaro; Hildegund C J Ertl
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Genes of the major histocompatibility complex and the evolutionary genetics of lifespan.

Authors:  M D Crew
Journal:  Genetica       Date:  1993       Impact factor: 1.082

Review 5.  Pathogenesis of neuroimmunologic diseases. Experimental models.

Authors:  C S Constantinescu; B Hilliard; T Fujioka; M K Bhopale; D Calida; A M Rostami
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  WNT/β-Catenin Signaling Regulates Multiple Steps of Myogenesis by Regulating Step-Specific Targets.

Authors:  Akiko Suzuki; Richard C Pelikan; Junichi Iwata
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

7.  Histological and transcriptome-wide level characteristics of fetal myofiber hyperplasia during the second half of gestation in Texel and Ujumqin sheep.

Authors:  Hangxing Ren; Li Li; Hongwei Su; Lingyang Xu; Caihong Wei; Li Zhang; Hongbin Li; Wenzhong Liu; Lixin Du
Journal:  BMC Genomics       Date:  2011-08-14       Impact factor: 3.969

8.  Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells.

Authors:  D Lauri; C De Giovanni; T Biondelli; E Lalli; L Landuzzi; A Facchini; G Nicoletti; P Nanni; E Dejana; P L Lollini
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.

Authors:  G K Pavlath; T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.